BC02 Screened out but not referred in: the unmeasured psychiatric referral gap for body dysmorphic disorder in cosmetic practices

Abstract

Body dysmorphic disorder (BDD) affects up to 18.6% of aesthetic cohorts compared with 1.7–2.9% of people in the population as a whole. Professional bodies recommend psychological assessment before cosmetic intervention and referral to mental health services if BDD is suspected. We examined the gap between recommended assessment and referral standards and real-world practice, assessed how well literature captures referral conversion (screening to specialist assessment), and identified barriers preventing completion of specialist mental health assessment. This was a targeted review of aesthetic surgery meta-analyses, dermatology and plastic surgery guidelines, aesthetic practice safety documents, and psychiatric assessment resources examining prevalence data, referral pathways and barriers to mental health engagement. Although the prevalence of BDD in aesthetic settings has been extensively studied, published literature rarely captures referral conversion rates. Despite validated high-­accuracy screening tools (Body Dysmorphic Disorder Questionnaire has sensitivity of 100% and specificity of 89–93%), recent database evidence highlights ongoing missed detection. In a cohort of 226 374 patients undergoing cosmetic surgery (August 2002 to August 2022), 52.1% of BDD diagnoses occurred only after procedures. Barriers span the patient level (denial, doctor shopping), clinician level (concerns about conflict, reputational or financial impact, limited training) and system level (lack of structured pathways, absence of warm handover mechanisms). Quantitative studies measuring these factors are minimal. UK literature documents BDD prevalence and provides screening tools but lacks referral conversion or follow-through metrics. Professional guidelines recommend specialist evaluation for suspected BDD, yet referral completion rates remain unmeasured and implementation inconsistent. The absence of referral conversion data and evidence of missed diagnoses highlight critical safety gaps. Priority actions include auditing current screening and referral practices, establishing clear referral triggers and destinations, implementing warm handover mechanisms, and developing integrated pathways between cosmetic and mental health services.